U R Kees - JoVE Visualize

Showing results (21-30 of 66) with videos related to

Pageof 7

Sort By:

Leukemia|April 1, 1990

Characterization of an interleukin-2 dependent human leukemic cell line, PER-315, with an immature T cell phenotype which does not express the tac antigenU R Kees, J Ford, P R Ranford, et al.

Cancer Genetics and Cytogenetics|April 1, 1992

Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridizationT L McRobert, C Rudduck, U R Kees, et al.

Gene|June 3, 1999

Genomic structure, tissue expression and chromosomal location of the LIM-only gene, SLIM1W K Greene, E Baker, T H Rabbitts, et al.

Blood|June 1, 1997

Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcomeU R Kees, P R Burton, C Lü, et al.

Journal of Immunological Methods|January 12, 1994

A new human cell line for the molecular dissection of the requirement for interleukin-1 in the production of interleukin-2 by immature T cellsU R Kees, S E Peroni, P R Ranford, et al.

Oncogene|October 5, 1995

HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotypeP D Salvati, P R Ranford, J Ford, et al.

Oncogene|July 5, 2011

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63L D Gamble, U R Kees, D A Tweddle, et al.

Pediatric Hematology and Oncology|January 1, 1993

Late leukemic relapse 10 years from diagnosis in a child on recombinant human growth hormoneD L Baker, U R Kees, P J Price, et al.

Blood Cancer Journal|April 15, 2014

The evolution of clinical trials for infant acute lymphoblastic leukemiaR S Kotecha, N G Gottardo, U R Kees, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998

Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathwayR M Bingisser, P A Tilbrook, P G Holt, et al.

Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:

Pageof 7

Leukemia|April 1, 1990

Characterization of an interleukin-2 dependent human leukemic cell line, PER-315, with an immature T cell phenotype which does not express the tac antigenU R Kees, J Ford, P R Ranford, et al.

Cancer Genetics and Cytogenetics|April 1, 1992

Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridizationT L McRobert, C Rudduck, U R Kees, et al.

Gene|June 3, 1999

Genomic structure, tissue expression and chromosomal location of the LIM-only gene, SLIM1W K Greene, E Baker, T H Rabbitts, et al.

Blood|June 1, 1997

Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcomeU R Kees, P R Burton, C Lü, et al.

Journal of Immunological Methods|January 12, 1994

A new human cell line for the molecular dissection of the requirement for interleukin-1 in the production of interleukin-2 by immature T cellsU R Kees, S E Peroni, P R Ranford, et al.

Oncogene|October 5, 1995

HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotypeP D Salvati, P R Ranford, J Ford, et al.

Oncogene|July 5, 2011

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63L D Gamble, U R Kees, D A Tweddle, et al.

Pediatric Hematology and Oncology|January 1, 1993

Late leukemic relapse 10 years from diagnosis in a child on recombinant human growth hormoneD L Baker, U R Kees, P J Price, et al.

Blood Cancer Journal|April 15, 2014

The evolution of clinical trials for infant acute lymphoblastic leukemiaR S Kotecha, N G Gottardo, U R Kees, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998

Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathwayR M Bingisser, P A Tilbrook, P G Holt, et al.

Pageof 7